by Truveta staff | Apr 15, 2025 | Research, Research Insights
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2017 and October 2024. During the early months of the COVID-19 pandemic, the rate of syphilis incidence (e.g., new infection) increased significantly, reaching a...
by Truveta Research | Apr 3, 2025 | Research, Research Insights
The vaccination rate by age six fluctuated between 2018 and 2021; however, rates have decreased since 2021. The rate in 2021 was 81.9% compared to 80.4% in 2024. This means for every 70 children, roughly one more child received two measles vaccines in 2021 compared to...
by Truveta Research | Apr 3, 2025 | Research, Research Insights
Measles vaccination rates for children under 24 months in 2024 remain lower than in 2020. In 2024, the average yearly measles vaccination rate for children by 13 months was 58.9% and 68.5% for children by 15 months. Vaccination patterns for children living in both...
by Truveta staff | Mar 31, 2025 | Research
The overall rate of respiratory virus-associated hospitalizations decreased in February, although influenza continues to be the leading cause of respiratory virus-associated hospitalizations (3.5% of all hospitalizations). Among children aged 0–4 years,...
by Terry Myerson, CEO | Mar 27, 2025 | News
At Truveta, our mission is Saving Lives with Data, and we are thinking about the HHS leadership mission of making American’s healthier, and how to help the talented scientists of HHS do more with less. We’d like to contribute to this important mission – starting...
